Left unchecked, they could cause oxidative damage to your cells
Benefits Semaglutide and liraglutide share a few common benefits, such as: Both drugs promote blood sugar control in patients with type 2 diabetes Semaglutide (Wegovy) and liraglutide (Saxenda) help reduce body weight in obese and overweight patients Both drugs have potential cardiovascular benefits and reduce the risk of heart attack, stroke, and cardiovascular death Side effects As semaglutide and liraglutide belong to the same class of drugs (GLP-1 receptor agonist), they have common side effects such as nausea, vomiting, diarrhea, constipation, stomach pain, injection site reaction, and pancreatitis
However, most users adopt seasonal protocols: higher dosing frequency (twice weekly maintenance) during low-UV months (OctoberMarch) to sustain pigmentation, lower frequency (once weekly) or temporary cessation during high-UV months (AprilSeptember) when natural sun exposure maintains melanin density
The above are suggestions for use of compounded tirzepatide while the FDA approved therapies remain on shortage
Published: Jun 1, 2026 Written by Klarity Editorial Team Published: Jun 1, 2026 Anthem Blue Cross Blue Shield plans in Michigan may cover weight loss treatment, including GLP-1 medications and obesity care, under pharmacy or medical benefits, though coverage varies significantly by plan and employer contract